Santen Pharmaceutical Co., Ltd. (SNPHY)
10.23
-0.45
(-4.21%)
USD |
OTCM |
Oct 06, 16:00
Santen Pharmaceutical Enterprise Value : 2.989B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 2.989B |
| October 05, 2026 | 3.133B |
| October 02, 2026 | 3.092B |
| October 01, 2026 | 3.275B |
| September 30, 2026 | 3.186B |
| September 29, 2026 | 3.090B |
| September 28, 2026 | 3.203B |
| September 25, 2026 | 3.252B |
| September 24, 2026 | 3.156B |
| September 23, 2026 | 3.191B |
| September 22, 2026 | 3.239B |
| September 21, 2026 | 3.217B |
| September 18, 2026 | 3.265B |
| September 17, 2026 | 3.378B |
| September 16, 2026 | 3.140B |
| September 15, 2026 | 3.291B |
| September 14, 2026 | 3.296B |
| September 11, 2026 | 3.323B |
| September 10, 2026 | 3.211B |
| September 09, 2026 | 3.453B |
| September 08, 2026 | 3.397B |
| September 04, 2026 | 3.471B |
| September 03, 2026 | 3.541B |
| September 02, 2026 | 3.310B |
| September 01, 2026 | 3.413B |
| Date | Value |
|---|---|
| August 31, 2026 | 3.561B |
| August 28, 2026 | 3.509B |
| August 27, 2026 | 3.455B |
| August 26, 2026 | 3.641B |
| August 25, 2026 | 3.485B |
| August 24, 2026 | 3.487B |
| August 21, 2026 | 3.509B |
| August 20, 2026 | 3.685B |
| August 19, 2026 | 3.535B |
| August 18, 2026 | 3.578B |
| August 17, 2026 | 3.689B |
| August 14, 2026 | 3.567B |
| August 13, 2026 | 3.614B |
| August 12, 2026 | 3.673B |
| August 11, 2026 | 3.691B |
| August 10, 2026 | 3.650B |
| August 07, 2026 | 3.484B |
| August 06, 2026 | 3.747B |
| August 05, 2026 | 3.628B |
| August 04, 2026 | 3.443B |
| August 03, 2026 | 3.362B |
| July 31, 2026 | 3.501B |
| July 30, 2026 | 3.496B |
| July 29, 2026 | 3.529B |
| July 28, 2026 | 3.546B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 84.77B |
| Daiichi Sankyo Co., Ltd. | 30.92B |
| Eisai Co., Ltd. | 8.174B |
| Chugai Pharmaceutical Co., Ltd. | 57.63B |
| Ono Pharmaceutical Co., Ltd. | 6.092B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 45.18M |
| Revenue (Quarterly) | 432.73M |
| Total Expenses (Quarterly) | 387.58M |
| EPS Diluted (Quarterly) | 0.1399 |
| Gross Profit Margin (Quarterly) | 54.66% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 7.51% |
| Operating Earnings Yield | 8.78% |